Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - Priority Announcement: INMD Start Up Funds (bridge funding)

Université Laval

$100,000.00

Impact of diabetes on tau pathogenesis in vivo

FY 2009-10

Summary
Alzheimer's disease (AD) is the most common form of dementia. It is an incurable, degenerative and terminal disease that afflicts an estimated 27 million people worldwide. In the brain, it is characterized by the presence of two protein aggregates: amyloid plaques, and neurofibrillary tangles (NFTs). NFTs are composed of bundles of aggregated tau protein. There is clinical evidence that diabetes is associated with an increased risk of AD, but there is very little understanding of the mechanism by which diabetes could affect AD. This project will study the impact of diabetes on tau protein in the mouse brain. We hope that, by providing a mechanistic explanation of the effects of diabetes on an aspect of AD pathology, we will pave the way to new therapeutics strategies focused on reducing the risk or retarding the development of AD, especially in a context of increased incidence of diabetes in the young population that predicts higher incidence of senile dementia in the coming years.
Program
Operating Grant - Priority Announcement: INMD Start Up Funds (bridge funding)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
198306
Name
Planel Emmanuel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
Impact of diabetes on tau pathogenesis in vivo
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: INMD Start Up Funds (bridge funding)
Keyworddelim
Alzheimer'S Disease; Diabetes Mellitus; Tau Pathology; Transgenic Mouse Models
Abstract
Alzheimer's disease (AD) is the most common form of dementia. It is an incurable, degenerative and terminal disease that afflicts an estimated 27 million people worldwide. In the brain, it is characterized by the presence of two protein aggregates: amyloid plaques, and neurofibrillary tangles (NFTs). NFTs are composed of bundles of aggregated tau protein. There is clinical evidence that diabetes is associated with an increased risk of AD, but there is very little understanding of the mechanism by which diabetes could affect AD. This project will study the impact of diabetes on tau protein in the mouse brain. We hope that, by providing a mechanistic explanation of the effects of diabetes on an aspect of AD pathology, we will pave the way to new therapeutics strategies focused on reducing the risk or retarding the development of AD, especially in a context of increased incidence of diabetes in the young population that predicts higher incidence of senile dementia in the coming years.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Planel, Emmanuel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
Université Laval - $100,000 Grant (2009-10) | Canada Spends